Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide
Pfizer has announced the global withdrawal of its sickle cell disease treatment, Oxbryta (voxelotor), which was priced at approximately $125,000 ...
Recent News
- MasteryHive to host Exclusive AI Leadership Workshop for Banking and Insurance Executives – September 24
- Droomwork launches to empower African Freelance Talents to connect with local and global work opportunities With talent matching innovation
- Meet Nigerian governors who built their careers in private sector before politics
